Aptorum Group Limited (NASDAQ: APM), a Hong Kong based pharmaceutical company currently in the preclinical stage, dedicated to developing and commercializing therapeutic projects and diagnostic technologies to tackle unmet medical needs, today announced that senior management will present a business overview and update at the upcoming Barclays Global Healthcare Conference on Thursday, March 14th, 2019 at 2:35 p.m. ET.
About Aptorum Group Limited
We are a Hong Kong based pharmaceutical company currently in the preclinical stage, dedicated to developing and commercializing a broad range of therapeutic and diagnostic technologies to tackle unmet medical needs. We are pursuing therapeutic and diagnostic projects in neurology, infectious diseases, gastroenterology, oncology and other disease areas. We also have projects focused on non-therapeutic area such as surgical robotics as well as the operations of our medical clinic in Hong Kong, Talem Medical, with the initial focus on treatment of chronic diseases resulting from modern sedentary lifestyles and aging population.
For more information about the Company, please visit www.aptorumgroup.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190304005723/en/
Contacts
Aptorum Group
Sabrina Khan, Chief Financial Officer
Phone: +852 2117 6611
Email: Investor.relations@aptorumgroup.com
Source: Aptorum Group Limited
View this news release online at:
http://www.businesswire.com/news/home/20190304005723/en
